Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
In Africa, a U.S. funding loss will be critical to HIV programs in countries like Uganda, Mozambique and Tanzania.
With the death of a student last year after a spider bite, it is good to know what action you should take if you are bitten.
Pune: The western Indian city of Pune is seeing an unusually large cluster of cases of a paralysing neurological disorder, in ...
Addresses the significant threat of antimicrobial resistance.
A sore throat usually isn't serious enough for a trip to the doctor, and many natural remedies can help ease your symptoms, ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated ...
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...
Parents of children diagnosed with Guillain-Barré Syndrome (GBS) at Kashibai Navale Hospital and Medical College (KNHMC) have ...
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Scientists at the Indian Institute of Technology (IIT) Roorkee have uncovered a crucial regulatory mechanism in Acinetobacter baumannii -- a highly drug-resistant superbug responsible for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback